Tymlos is a synthetic peptide analog of parathyroid hormone-related protein (PTHrP) for the treatment of osteoporosis in postmenopausal women who are at increased risk for fracture or have failed or are intolerant to other available osteoporosis therapies. It is self-administered once daily by subcutaneous (SC) injection.
If you have a Hayes login, click here to view the full report on the Knowledge Center.